Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8892190 | NOVADAQ TECH | Method and apparatus for performing intra-operative angiography |
Aug, 2020
(3 years ago) | |
US6915154 | NOVADAQ TECH | Method and apparatus for performing intra-operative angiography |
Aug, 2021
(2 years ago) | |
US7881777 | NOVADAQ TECH | Method and apparatus for performing intra-operative angiography |
Sep, 2021
(2 years ago) | |
US9421280 | NOVADAQ TECH | Real time imaging during solid organ transplant |
Nov, 2025
(1 year, 6 months from now) | |
US8185176 | NOVADAQ TECH | Method and apparatus for vasculature visualization with applications in neurosurgery and neurology |
Jun, 2028
(4 years from now) | |
US8647605 | NOVADAQ TECH | Real time imaging during solid organ transplant |
Feb, 2029
(4 years from now) | |
US8406860 | NOVADAQ TECH | Method for evaluating blush in myocardial tissue |
Apr, 2029
(4 years from now) | |
US10631746 | NOVADAQ TECH | Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography |
Aug, 2035
(11 years from now) | |
US11712320 | NOVADAQ TECH | Methods and systems to automate surgical interventions |
Jul, 2039
(15 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Indication(I-911) | Jun 05, 2026 |
New Product(NP) | Nov 21, 2021 |
Market Authorisation Date: 21 November, 2018
Treatment: Visualization of vessels, blood flow and tissue perfusion of vessel graft in vascular, gastrointestinal, organ transplant, and plastic, micro- and reconstructive, including minimally invasive, surgery...
Dosage: POWDER;INTRAVENOUS, INTERSTITIAL